Astaxanthin

DB06543InvestigationalSmall molecule

Astaxanthin is a keto-carotenoid in the terpenes class of chemical compounds. It is classified as a xanthophyll but it is a carotenoid with no vitamin A activity. It is found... It is found in the majority of aquatic organisms with red pigment.

Primary indication: Investigated for use/treatment in eye disorders/infections, cancer/tumors (unspecified), and asthma.Curator reviewed
Formula / weight: C₄₀H₅₂O₄ · 596.852 g/mol (avg)

Resolves to

Compound

UNII8XPW32PR7ICAS472-61-7ChEMBLCHEMBL1255871ChEBI40968PubChem5281224KEGGC08580

Clinical / RWD

RxNorm18451

Structure

InChIKeyMQZIGYBFDRPAKN-UWFIBFSHSA-NSMILESC\C(\C=C\C=C(/C)\C=C\C1=C(C)C(=O)[C@@H](O)CC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C(=O)[C@@H](O)CC1(C)C

Targets

P25963NFKBIA

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

640Drug interactionsStructured to mechanism, not free text

10Clinical trialsPhase, status and sponsor resolved per trial

9Marketed productsAcross 2 countries and 9 labellers

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Astaxanthin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account